-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In a new study, researchers from the University of Birmingham, the University of Keele, the University of Liverpool, the University of Copenhagen, Denmark, and the San Rafael Institute of Science in Italy have discovered in the laboratory a substance commonly used to treat fatty substances in the blood Abnormal levels of approved drugs can reduce infections caused by the SARS-CoV-2 virus by up to 70%
These authors confirmed that fenofibrate and its active form (fenofibrate acid) can significantly reduce SARS-CoV-2 infection in human cells in the laboratory
The authors are now calling for clinical trials to test the drug in hospitalized COVID-19 patients
SARS-CoV-2 is a coronavirus that causes COVID-19
ACE2 dimerization determination, the picture is from Frontiers in Pharmacology, 2021, doi:10.
Note: The original text has been deleted
Reference materials:
Scott P.